These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4042558)

  • 1. Change in enzyme content and manufacturer of Viokase.
    Berardi RR; Colvin CL
    Clin Pharm; 1985; 4(4):388. PubMed ID: 4042558
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro enzyme activities of five commercially available pancreatic supplements.
    Shaw DW; Barbezat GO
    N Z Med J; 1982 Jun; 95(710):424-5. PubMed ID: 6180364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc-binding ligands in Viokase and role in zinc absorption.
    Hurley LS; Lönnerdal B
    J Pediatr; 1981 Aug; 99(2):328-30. PubMed ID: 7252704
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic enzyme replacement therapy.
    Morrow JD
    Am J Med Sci; 1989 Nov; 298(5):357-9. PubMed ID: 2683774
    [No Abstract]   [Full Text] [Related]  

  • 11. Exocrine pancreatic insufficiency in a cat.
    Browning T
    Aust Vet J; 1998 Feb; 76(2):104-6. PubMed ID: 9578779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of exocrine pancreatic insufficiency: where can progress come from?].
    Gosselin M
    Gastroenterol Clin Biol; 1988 Nov; 12(11):783-6. PubMed ID: 3220230
    [No Abstract]   [Full Text] [Related]  

  • 13. Metal-binding ligands in Viokase.
    Martin MT; Jacobs FA; Brushmiller JG
    J Pediatr Gastroenterol Nutr; 1983; 2(3):555-8. PubMed ID: 6620061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The active site composition of porcine pancreatic lipase: possible involvement of lysine.
    Kaimal TN; Saroja M
    Biochim Biophys Acta; 1989 Dec; 999(3):331-4. PubMed ID: 2513889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic enzyme products: digesting the changes.
    Giuliano CA; Dehoorne-Smith ML; Kale-Pradhan PB
    Ann Pharmacother; 2011 May; 45(5):658-66. PubMed ID: 21540403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative determination of lipase activity in pharmaceutical preparations].
    Sawicka T; Wilk M; Tautt J
    Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):625-7. PubMed ID: 1669129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.